What are Dogwood Therapeutics's total assets?

Dogwood Therapeutics (DWTX) holds $95.2M in total assets, down 1.8% year over year.

How much debt does Dogwood Therapeutics have?

Dogwood Therapeutics carries $144.9K in total debt against $80.6M of shareholders' equity, a debt-to-equity ratio of 0.00.

How much cash does Dogwood Therapeutics have?

Dogwood Therapeutics holds $13.2M in cash and equivalents.

Can Dogwood Therapeutics cover its short-term obligations?

Its current ratio is 5.86 — current assets exceed current liabilities.

Where does Dogwood Therapeutics's balance sheet data come from?

Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Dogwood Therapeutics DWTX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$6.52M-56.1%	$14.85M+348%	$3.32M-52.8%	$7.03M-49.8%
Prepaid expenses and other current assets	$6.36M+87.1%	$3.4M+9.0%	$3.12M-37.0%	$4.95M-40.4%
Total current assets	$8.43M-49.0%	$16.54M+297%	$4.17M-50.2%	$8.37M-46.9%
Property and equipment, net	$12.75K-24.1%	$16.81K—	——	——
Operating lease right-of-use assets	$163.14K-20.7%	$205.84K—	——	——
Goodwill	$12.4M+5.0%	$11.81M—	——	——
Intangible assets, net	$68.99M+5.0%	$65.71M—	——	——
Deferred tax assets	$12.11M+7.0%	$11.31M—	$0—	——
Total assets	$90.17M-4.4%	$94.31M+2,164%	$4.17M-50.2%	$8.37M-46.9%
Accounts payable	$3M+42.6%	$2.1M+215%	$666.68K-70.4%	$2.25M+31.2%
Accrued expenses	$2.24M+18.3%	$1.89M+668%	$246.64K-47.5%	$470.1K-49.0%
Operating lease liabilities, current	$56.84K+14.4%	$49.7K—	——	——
Total current liabilities	$3.06M-3.7%	$3.18M+786%	$358.55K-65.6%	$1.04M-18.2%
Operating lease liabilities, non-current	$105.76K-31.7%	$154.89K—	——	——
Operating Lease Liabilities (Total)	$162.6K-20.5%	$204.58K—	——	——
Total liabilities	$15.27M-49.1%	$30.03M+8,275%	$358.55K-65.6%	$1.04M-18.2%
Common stock	$2.97K+2,136%	$133+72.7%	$77-95.8%	$1.83K+120%
Additional paid-in capital	$183.86M+171%	$67.86M+3.5%	$65.58M+3.3%	$63.5M+8.7%
Retained earnings	-$108.08M-46.4%	-$73.82M-20.1%	-$61.47M-9.4%	-$56.17M-27.9%
Accumulated other comprehensive income (loss)	-$587.04K+84.8%	-$3.86M—	——	——
Treasury stock	$299.13K0.0%	$299.13K0.0%	$299.13K—	——
Total stockholders' equity	$74.9M+840%	-$10.12M-366%	$3.81M-48.0%	$7.33M-49.5%
Total liabilities and stockholders' equity	$90.17M-4.4%	$94.31M+2,164%	$4.17M-50.2%	$8.37M-46.9%
Net Investment in Lease	$163.14K-20.7%	$205.84K—	——	——
Other intangible assets—net	$68.99M+5.0%	$65.71M—	——	——
Operating lease right-of-use assets	$163.14K-20.7%	$205.84K—	——	——
Operating Lease Right-of-Use Assets in Other Assets	$163.14K-20.7%	$205.84K—	——	——
Other Commercial Liabilities	$2.24M+18.3%	$1.89M+668%	$246.64K-47.5%	$470.1K-49.0%
Accrued Liabilities, Current	$2.24M+18.3%	$1.89M+668%	$246.64K-47.5%	$470.1K-49.0%
Operating Lease Sublease Revenue Security Deposit Current	——	——	——	——
Total debt	$162.6K-20.5%	$204.58K—	——	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$2.97K+2,136%	$133+72.7%	$77-95.8%	$1.83K+120%
Total Stockholders' Equity Before Treasury Stock	$75.2M+865%	-$9.83M-339%	$4.11M-44.0%	$7.33M—
Deferred Finance Costs Noncurrent Net	$158.96K—	——	——	——
Deferred income taxes	$12.11M+7.0%	$11.31M—	$0—	——
Operating Lease Sublease Revenue Security Deposit Non Current	——	——	——	——
Prepaid ship and debits	$19.04K+5.0%	$18.13K—	——	——
Stockholders' Equity before Treasury Stock	$75.2M+865%	-$9.83M-339%	$4.11M-44.0%	$7.33M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Dogwood Therapeutics's total assets?: Dogwood Therapeutics (DWTX) holds $95.2M in total assets, down 1.8% year over year.
How much debt does Dogwood Therapeutics have?: Dogwood Therapeutics carries $144.9K in total debt against $80.6M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does Dogwood Therapeutics have?: Dogwood Therapeutics holds $13.2M in cash and equivalents.
Can Dogwood Therapeutics cover its short-term obligations?: Its current ratio is 5.86 — current assets exceed current liabilities.
Where does Dogwood Therapeutics's balance sheet data come from?: Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.